{
    "organizations": [],
    "uuid": "5c2fc7024b4443a976a06962bee0686a646fb2c2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-nod-for/brief-strides-shasun-gets-u-s-fda-nod-for-tenofovir-disoproxil-fumarate-tablets-idUSFWN1PN032",
    "ord_in_thread": 0,
    "title": "BRIEF-Strides Shasun Gets U.S. FDA Nod For Tenofovir Disoproxil Fumarate Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - Strides Shasun Ltd:\n* GETS U.S. FDA NOD FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS\n* DRUG TO BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY IN BANGALORE Source text - bit.ly/2DXpeei Further company coverage:\n ",
    "published": "2018-01-29T11:46:00.000+02:00",
    "crawled": "2018-01-29T21:56:53.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "stride",
        "shasun",
        "ltd",
        "get",
        "fda",
        "nod",
        "tenofovir",
        "disoproxil",
        "fumarate",
        "tablet",
        "drug",
        "manufactured",
        "co",
        "oral",
        "dosage",
        "facility",
        "bangalore",
        "source",
        "text",
        "company",
        "coverage"
    ]
}